NACDS Endorses Bill to Protect Patients from Counterfeit Medication Trafficking

Published Online: Wednesday, December 7, 2011
Follow Pharmacy_Times:
The National Association of Chain Drug Stores (NACDS) offered its support for legislation that would protect the health and safety of patients by increasing penalties for  criminals that engage in the harmful practice of trafficking in counterfeit medications.

Introduced by US Senator Patrick Leahy (D,VT), S. 1886, the Counterfeit Drug Penalty Enhancement Act of 2011 would impose harsher penalties for criminals who produce, buy, sell or purchase counterfeit medications. NACDS sent a letter to Sen. Leahy, offering its endorsement of the bill.

“NACDS and the chain pharmacy industry applaud your leadership in taking steps to protect American consumers by advocating for stricter sentences for criminals in the counterfeit medicine business. Presently, the federal penalty for a counterfeiting crime is typically three years. We believe that stronger deterrents, as provided in your legislation, are more appropriate for these potentially deadly crimes involving counterfeit medicine,” NACDS stated.

In the letter, NACDS applauded the bill citing it would further help efforts to deter criminals from preying on unsuspecting consumers, jeopardizing their health and safety.
“Under current federal law, no distinction exists between counterfeit medicines and other counterfeit products. Your important legislation recognizes the greater threat of counterfeit medicines and imposes penalties and deterrence commensurate with that threat,” the organization said.

NACDS has supported initiatives to protect U.S. consumers from counterfeit and diverted drugs. NACDS endorsed the SAFE Doses Act, introduced by US Senator Charles E. Schumer (D, NY), which would provide law enforcement with critical tools to break up sophisticated crime rings that harm consumers by attempting to resell stolen medical products on the black market.

To read the letter, click here.
Related Articles
Pharmacy operations can be improved by investing in continuing education for pharmacy technicians.
An island community is making do with a temporary pharmacy after its sole pharmacy was destroyed in a fire on January 25, 2015.
Although retail pharmacists in California are permitted to sell nonprescription syringes under legislative efforts to prevent HIV transmission among injection drug users (IDUs), recent research uncovered that many pharmacies still limit syringe access.
mscripts and Avella Specialty Pharmacy have recently completed analyzing data demonstrating the effectiveness of mobile pharmacy apps in helping HIV patients better manage their disease through improved medication adherence. Results from this analysis show that HIV patients using a mobile app which provides refill reminders, dosage reminders and other prescription management functionality are 2.9 times more likely to be adherent.
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$